- September 22, 2023 - Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2024, 2025, and 2026 (P50 Clinical Trial Required). See NOFO PAR-23-284.
National Cancer Institute (NCI)
The purpose of this Notice is to announce a change to the following section of PAR-23-284 "Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2024, 2025, and 2026 (P50 Clinical Trial Required)"
Part 2. Full Text of Announcement
Section IV. Application and Submission Information
2. Content and Form of Application Submission
Research & Related Other Project Information (Overall)
Other Attachments:
Plan for Enhancing Diverse Perspectives (PEDP)
Current language:
In an Other Attachment entitled “Plan for Enhancing Diverse Perspectives”, all applicants must include a summary of strategies to advance the scientific and technical merit of the proposed project through expanded inclusivity. The PEDP should provide a holistic and integrated view of how enhancing diverse perspectives is viewed and supported throughout the application and can incorporate elements with relevance to any review criteria (significance, investigator(s), innovation, approach, and environment) as appropriate. Where possible, applicant(s) should align their description with these required elements within the research strategy section. The PEDP will vary depending on the scientific aims, expertise required, the environment and performance site(s), as well as how the project aims are structured. The PEDP may be no more than 1-page in length and should include a timeline and milestones for relevant components that will be considered as part of the review.
Revised language (in italics):
In an Other Attachment entitled “Plan for Enhancing Diverse Perspectives”, all applicants must include a summary of strategies to advance the scientific and technical merit of the proposed project through expanded inclusivity. The PEDP should provide a holistic and integrated view of how enhancing diverse perspectives is viewed and supported throughout the application and can incorporate elements with relevance to any review criteria (significance, investigator(s), innovation, approach, and environment) as appropriate. Where possible, applicant(s) should align their description with these required elements within the research strategy section. The PEDP will vary depending on the scientific aims, expertise required, the environment and performance site(s), as well as how the project aims are structured. The PEDP may be no more than 3-pages in length and should include a timeline and milestones for relevant components that will be considered as part of the review.
Steven F. Nothwehr, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-5685
Email: nothwehrs@mail.nih.gov
and Human Services (HHS)
